Information technologyActelion began in a garage—now its founding couple has $1 billion and a new biotech firm | The Wall Street Journal
Jean-Paul and Martine Clozel had to sell their house and work out of a rented garage when they started biotech company Actelion. Twenty years later, after selling the Swiss company to Johnson & Johnson in an unusual, $30 billion deal, the husband-and-wife team is starting over again.
A mysterious medical condition gets a name—and a genetic link to deafness | The Washington Post
He is one in a million, literally. Born deaf-blind and with a condition, osteopetrosis, that makes bones both dense and fragile, 6-year-old Orion Theodore Withrow is among an unknown number of children with a newly identified genetic disorder that researchers are just beginning to decipher.
Medical devices and equipmentMedical device makers stand to gain if Neil Gorsuch approved for Supreme Court | Star Tribune
One of the most strongly expressed opinions Gorsuch would bring to the nation’s highest judicial body is a belief that federal law protects medical device makers from lawsuits filed by patients injured by their products.
Pharmaceuticals’Right to try’ laws expose dying patients to exploitation, ethicists warn | Kaiser Health News
In the past three years, 33 U.S. states have passed laws aimed at helping dying people get easier access to experimental treatments. Supporters say these patients are just looking for the “right to try” these treatments.
Safety, quality and clinical practiceBirth defects rise twentyfold in mothers with Zika, CDC finds | The New York Times
American mothers infected with the Zika virus last year were 20 times as likely to give birth to babies with birth defects as mothers who gave birth two years before the epidemic, federal health officials said.